Colorectal Cancer (CRC) Screening Committee Material

In this section you can find presentations from the previous Colorectal Cancer Screening Committee meetings.

2022 | 2021 | 2020 | 2019 | 2018 | 2017


Virtual CRC SC Meeting at APDW 2022 in Xi’an, China
CRC SC Meeting on November 17, 2022 | Program

Third Asia Pacific Consensus Recommendations on Colorectal Cancer ScreeningView Recording Here

Hybrid Plenary Meeting in Vienna, Austria
Plenary Meeting on October 7, 2022 | Program

Session 1: CRC Screening policy update

Global CRC incidence and mortality trends
Linda Rabeneck (Canada)
EU Recommendations on cancer screening
Michael Kaminski (Poland)

Session 2: Risk stratification in CRC screening

Colonoscopy Prioritization
Revital Kariv (Israel)

Session 3: Participation in CRC screening

The role of Defensive Information Processing in
population-based colorectal cancer screening uptake

Nick Clarke (Ireland)
Reducing the footprint of CRC screening
Iris Seriese (Netherlands)

Session 4: Screen detected CRC

CRC: indication for ESD
Yutaka Saito (Japan)
Screen detected T1 CRC in the Netherlands
Lisa van der Shee (Netherlands)

Expert Working Group Meeting in Vienna, Austria
EWG Meeting on October 7, 2022

FIT for Screening

Association of Fecal Immunological Test with the risk of gastroesophageal cancer within a population with an intermediate risk for cancer
Zohar Levi (Israel)
A survey aimed to collect quantitative information about screening activity during the pandemic emergency
Carlo Senore (Italy)

PCCRC & Quality in Colonoscopy

Molecular pathways in post-colonoscopy versus prevalent colorectal cancers:
results from a population-based cohort study

Beatriz Carvalho (Netherlands)

Inequities in CRC Screening

Colorectal Cancer Screening during Pandemic
Samar Alhomoud (Saudi Arabia)
Participation during the Covid pandemic
Morten Rasmussen (Denmark)
Factors associated with participation in the Dutch CRC screening program
Esther Toes-Zoutendijk (Netherlands)

Surveillance after Colorectal Neoplasia

Post-surgery endoscopy surveillance
for colorectal cancer

Giulio Antonelli (Italy)
Surveillance after endoscopic excision of pT1 malignant polyp. Is that different?
Maria Pellisé & Rodrigo Jover (Spain)

Polyp detection, characterization, resection and AI

CADe, CADx – how good is it and how good should it be?
Roupen Djinbachian (Canada)
Beyond AI diagnosis: New evidence of ESD, suggesting a refined management of colorectal neoplasm
Yutaka Saito (Japan)

Hybrid Plenary Meeting in San Diego, USA
Plenary Meeting on May 20, 2022 | Program

Session 1: Early-onset

Prevalence of colorectal neoplasia in young individuals /
GIQuIC: Yield of screening 45–49-year-olds

Parth Trivedi (USA)
Fight CRC: Integrating Stakeholders with Research Initiatives in Early-onset Colorectal Cancer
Jennifer Kolb, Caitlin Murphy (USA)
Potential Effects of Lowering Colorectal Cancer Screening Age to 45 Years on Colonoscopy Demand, Case Mix, and Adenoma Detection Rate
Seth Crockett (USA)

Session 2: New tests

Review on regional variation in microbiome
Mingyang Song (USA)
Update for the WEO Expert Working Group on New Test Evaluation: Assessing the cost effectiveness of new tests
Uri Ladabaum (USA)

Session 3: Risk-based screening and encouraging uptake

Risk-based screening versus FIT for detecting advanced neoplasia: A within group comparison in a randomized controlled trial
Tim Kortlever (Netherlands)
Using Facebook to promote the uptake of colorectal cancer screening
Arlinda Ruco (Canada)
M-TICS: A study to assess the effectiveness of SMS-based interventions to increase participation in a population-based colorectal cancer screening program
Montse Garcia (Spain)

Session 4: Emerging trends

Green endoscopy
Heiko Pohl (USA)
How to measure equity by race and ethnicity and socio-economic status, and what to do about the results. An update along with results from recent letter in NEJM
Chyke Doubeni (USA)
Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study
David van Toledo (Netherlands)
Comparing Colorectal Cancer Screening Outcomes in the International Cancer Screening Network (ICSN): A Consortium Proposal
Iris Lansdorp-Vogelaar (Netherlands)

Hybrid Expert Working Group Sessions in San Diego, USA
EWG sessions on May 20, 2022 | Program

Session 1: EWGs Surveillance after Colorectal Neoplasia and Polyp detection, characterization, resection and AI

Why people at high risk remain at high risk after polyp excision
Samir Gupta (USA)
EPoS study update
Rodrigo Jover (Spain)
Incomplete resection, complete resection and polyp recurrence
Roupen Djinbachian (Canada)
Benefits and limitations of using CADx in colonoscopy: learning from the first comparative clinical trial
Sophie Williams (UK)

Session 2: EWGs FIT for Screening and Evaluation of new tests

A trial of 50,000 US Veterans who were randomized to colonoscopy vs. FIT
Jason Dominitz (USA)
Adherence to FIT Screening
Paul Limburg (USA)
Cost effectiveness of outreach strategy for stool-based CRC screening
Durado Brooks (USA)
Two-sample Fecal Immunochemical Testing as a Tool to avert Colonoscopy in Symptomatic Patients
Pieter Wisse (Netherlands)
Progress with consensus process | Uri Ladabaum’s presentation from plenary meeting
Robert Bresalier (USA)

Session 3: Case Studies: Impact of COVID-19

Impact of COVID Pandemic on FIT-Based CRC Screening Programs in 3 Countries: What Does Modeling Tell Us?
Iris Lansdorp-Vogelaar (Netherlands)
Impact of COVID Pandemic on CRC Screening Ontario: What Did We Learn?
Jill Tinmouth (Canada)
Impact of COVID Pandemic on FIT Use, Colonoscopy, and Neoplasia Detection: Lessons from Kaiser Permanente
Theodore Levin (USA)


Expert Working Groups: Inequities in CRC Screening & Screening in a COVID-19 Era
Webinar on December 9, 2021 | Program

The impact of delays in screening invitations on outcomes of screening: an analysis based on individual-level data
Esther Toes-Zoutendijk (Netherlands)
The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities
Jesse Nodora (USA)
Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study
Meghan Walker (Canada)

Expert Working Groups: PCCRC & Quality in Colonoscopy and Surveillance after Colorectal Neoplasia
Webinar on December 2, 2021 | Program

National PCCRC audit project in England – progress, logistics, lessons learned, how to implement elsewhere
Roland Valori (UK)
Colonoscopy provider reporting in Ontario, Canada
Jill Tinmouth (Canada)
Post-Colonoscopy Cancer: Giving Feedback to the Endoscopist
Silvia Sanduleanu (Netherlands)
The evidence on the effectiveness of surveillance: What is known, evidence gaps, future research
Amanda Cross (UK)
Should colonoscopy quality be integrated into surveillance recommendations?
Paulina Wieszczy (Poland)
Update on FORTE, including how to handle research as guidelines change
Robert Schoen (USA)

Expert Working Group: Polyp detection, characterization, resection and AI
Webinar on November 25, 2021 | Program

Embedding optical biopsy recommendation in the NICE statements in the UK and possibility to include AI in the NICE
James East (UK)
Standard polypectomy – how can we improve complete polyp resection?
Daniel von Renteln (Canada)
Polypectomy – Teaching and Training
Kevin Waschke (Canada)
Endoscopic resection for large colorectal polyps
Jeffrey Mosko (Canada)

Expert Working Groups: Evaluation of New Tests & FIT for Screening
Webinar on November 16, 2021 | Program

Report on consensus process of the guiding principles
Graeme Young (Australia)
What is a reasonable comparator test to run against for new tests
Carlo Senore (Italy)
Validation of a new test in CRC screening –How we did it.
Veerle Coupé, Beatriz Carvalho (Netherlands)
Gut microbiome biomarker for colorectal cancer and adenoma
Jun Yu (Hong Kong)

Virtual Plenary Meeting
on October 1, 2021 | Program

Session 1: Expert Working Group Session

WEO recommendation statement for dealing with future healthcare crises: a Delphi panel
Iris Lansdorp-Vogelaar (Netherlands)
Bowel Cancer Screening Uptake & CRC Diagnosis All Pathways – a four-year audit 2017-2020
Andrew Prentice (UK)
Updating the New Test Evaluation Guidelines
Carlo Senore (Italy)
Global burden of post-colonoscopy colorectal cancer – current status and future directions
Jeffrey Lee (USA)
Current status and future perspectives of polyp detection and characterization
Daniel von Renteln (Canada)
Optimizing surveillance: Less overall – but what to do in high-risk patients?
Rodrigo Jover (Spain)
Diagnostic yield using a FIT-based risk model was not better than FIT only: a randomized controlled trial in the second round of the Dutch colorectal cancer screening program
Tim Kortlever (Netherlands)

Session 2: Early-onset CRC

Prevalence of neoplasia and ADR targets in 45-49-year olds
Aasma Shaukat (USA)
Impact of family history of CRC on the prevention of early-onset CRC: a multicenter study
Maria Daca Alvarez (Spain)

Session 3: Non-invasive CRC Screening

Novel microbial-based stool markers for CRC and adenoma detection
Francis Chan (Hong Kong)

Session 4: AI in CRC Screening

AI for polyp detection – what is unknown?
Yuichi Mori (Norway)
Blood-based CRC screening using multiomics and artificial intelligence/machine learning
Theodore R. Levin (USA)

Virtual Plenary Meeting
on May 20, 2021 | Program

Session 1: COVID-19 / Risk stratification

Effect of COVID-19 on Colorectal Cancer Screening
Karen Canfell (Australia)
Risk stratified intervals for FIT screening
Iris Lansdorp-Vogelaar (Netherlands)
Risk stratification for screening in the wake of COVID-19
Marco Zappa (Italy)
Incorporating demographic algorithms to improve FIT screening
Patrick Bossuyt (Netherlands)

Session 2: Quality

Transforming colorectal cancer research findings into policy action
Gloria Coronado (USA)
Improving screening quality in Ontario, Canada
Catherine Dubé (Canada)

Session 3: Colonoscopy

Systematic review on tailoring surveillance of high-risk lesions
Sandra Baile-Maxia (Spain)
PCCRC – auditing report from the UK
Roland Valori (UK)
Is colonoscopy less effective in the right colon?
Ulrike Haug (Germany)
Analysis and categorization of PCCRCs using the WEO guidelines
Matt Rutter (UK)

Session 4: Multi-cancer screening with ctDNA/methylation markers

Review and reports from the latest studies
Robert Schoen (USA)
Design of trials going forward
Carlo Senore (Italy)

Expert Working Group: Screening in the COVID-19 Era
Webinar on May 11, 2021 | Program

COVID and Cancer Global Modeling Consortium: Projections of the long-term impact of disruptions to colorectal cancer (CRC) screening programs
Eleonora Feletto (Australia)
COVID-19 and the Dutch national CRC screening program: Short term outcomes and optimal strategies to mitigate long term impact
Tim Kortlever, Lucie de Jonge (Netherlands)
ICSN CRC working group initiative to monitor the impact of COVID-19 on CRC screening programs across the world
Carlo Senore (Italy)

Expert Working Group: Inequities in CRC Screening
Webinar on May 6, 2021 | Program

Advocating for a Medicaid Colorectal Cancer
Screening Performance Metric – Lessons
Learned and Progress to Date

Beverly Green (USA)
Barriers to colonoscopy in the English Bowel Screening Programme: findings from a key informant interview study
Robert Kerrison (UK)
Small-area Analysis of Participation Rates in a
Colorectal Cancer Screening Program in Catalonia

Montse Garcia (Spain)
Barriers to Bowel Screening in Welsh Prisons: A
Literature Review

Mary Keast (UK)

Expert Working Group: FIT for Screening
Webinar on April 29, 2021 | Program

CRC screening in COVID times
Sally Benton (UK)
Impact of program design on rates of rejected fecal tests in Ontario, Canada
Catherine Dubé (Canada)
The impact of COVID-19 on the FIT-based program in the Netherlands
Tim Kortlever (Netherlands)
Using prior Hb concentration for risk-stratified intervals of FIT screening – rationale for and design of a randomized controlled trial in the Netherlands
Iris Lansdorp-Vogelaar (Netherlands)
Variation in f-Hb concentration means that 2 samples are better than one
Graeme Young (Australia)

Expert Working Groups: Right-Sided Lesions/Interval Cancers and Surveillance after Colorectal Neoplasia
Webinar on April 22, 2021 | Program

Is there a role of an interval FIT for the prevention of PCCRC?
Han-Mo Chiu (Taiwan)
Are PCCRCs more lethal compared to detected CRCs? | The view from Sweden
Anna Forsberg (Sweden)
Are PCCRCs more lethal compared to detected CRCs? | The view from Canada
Fahima Dossa (Canada)
Are we successfully reducing CRC risk in patients with
baseline High Risk Adenomas?

Uri Ladabaum (USA)

Expert Working Group: Evaluation of New Tests
Webinar on April 13, 2021 | Program

What is the screening target?
Uri Ladabaum (USA)
How good need the new test be? Graeme Young (Australia)
Discussion on: What is the screening target?
Beatriz Carvalho (Netherlands)
Algorithms in CRC screening 
Tim Kortlever (Netherlands)
Design issues
Carlo Senore (Italy)
Statistical approaches
Patrick Bossuyt (Netherlands)
How do we get new CRC screening tests from bench to bedside?
Robert Bresalier (USA)

Expert Working Group: Polyp detection, characterization, resection and AI
Webinar on April 8, 2021 | Program

How do we handle the detection of an increasing number of tiny adenomas?
Masau Sekiguchi (Japan)
Is the idea of R&D still relevant? Daniel von Renteln (Canada)


Expert Working Group: Coalition to Reduce Inequities in CRC Screening
Webinar on November 20, 2020 | Program

Disgusted, embarrassed, afraid: Affective predictors of colonoscopy avoidance 
Lynne Klasko-Foster (USA)
Covid-19 and follow up of patients with abnormal FIT 
Andrew Prentice (UK)
The impact of hypothetical PErsonalised Risk Information on informed choice and intention to undergo Colorectal Cancer screening colonoscopy in Scotland (PERICCS)
Jayne Digby (UK)
Interventions to improve the follow-up of positive FIT: An international survey of screening programs 
Kevin Selby (Switzerland)

Colorectal Cancer Screening Committee Virtual Meeting (Europe)
UEG Week | October 9, 2020 | CRC SC Abstracts | Program

Session 1: Colorectal Cancer Screening in a COVID-19 era

COVID-19: The forefront of virus management
Ernst Kuipers (Netherlands)
Global news on CRC Screening in the COVID-19 era
Stephen Halloran (UK)
Optimizing Endoscopy Efficiency and flow during and after COVID-19
Aasma Shaukat (USA)
COVID-19: Endoscopy services, PPE, pre-procedure testing
Asadur Tchekmedyian (Uruguay)
Experience and Impact of Delays in Endoscopy on Bowel Cancer Screening
Siwan Thomas-Gibson (UK)
Changes in the numbers of US patients with newly identified cancer before and during COVID-19
Randy Howard (USA)

Session 2: Outreach & increasing participation in population-based programs

Implementing Ontario’s CRC screening program: The first 10 years 
Linda Rabeneck (Canada)
Organized CRC screening outreach Eeforts in various countries and health systems
Jason Dominitz (USA)
Model-based comparison of measures for longitudinal screening adherence
Veerle Coupé (Netherlands)

Session 3: Looking hard for polyps

Artificial Intelligence for polyp detection
Raf Bisschops (Belgium)
Optimizing polyp resection
Heiko Pohl (USA)
Clinical features, outcomes and risk factors for bleeding after endoscopic resection of submucosal invasive colorectal
Ji-Taek Hong (Korea)
Polyp Surveillance Guidelines from the US and EU
Samir Gupta (USA)

Session 4: Programmatic issues

Update on Early-Onset Colorectal Cancer (EOCRC)
Thomas Imperiale (USA)
Launching the European Commission Initiative on Colorectal Cancer (ECICC)
Elena Parmelli (Italy)
Post-Colonoscopy CRC over the Globe
Matthew Rutter (UK)


Colorectal Cancer Screening Committee Meeting Barcelona (Europe) UEG Week 2019 | October 18, 2019 | CRC SC Abstracts | Program

Session 1: Colonoscopy: good, better, best? 

Training for optical recognition of early cancer
Krijn Haasnoot (Netherlands)
Update on the CONFIRM study
Jason Dominitz (USA)

Session 2: New light on CRC epidemiology

Early onset colorectal cancer
Marc Bardou (France)
Effect of CRC screening on incidence
Gavin Clark (UK)
Comparison of screen-detected and interval cancers in FIT screening
Isabel Portillo Villares (Spain)
Mortality due to screen-detected and interval cancer
Montse Garcia (Spain)

Session 3: The international perspective: what is happening…where? 

Cancer screening in five continents: the IARC initiative
Eric Lucas (France)
Update on CRC screening in Germany
Urlike Haug (Germany)
Impact of CRC screening on incidence and mortality in the Czech Republic
Stepan Suchanek (Czech Republic)

Session 4: Issues to consider…

Increase in faecal occult bleeding with time
Robert Steele (UK)

Expert Working Groups

EWG: WEO Coalition to Reduce Inequities in CRC Screening

My best 10 seconds campaign
Jolanta Gore Booth (Belgium)
Improving uptake of bowel cancer screening in the South Asian community
Lesley Smith (UK)
Ethnic differences in bowel cancer screening awareness: findings from a pharmacy-based community survey
Andrew Prentice (UK) & Sarah Marshall (UK)
Exploring non-attendance at colonoscopy among socioeconomically deprived and ethnically diverse populations taking part in FIT-based CRC screening
Robert Kerrison (UK)

EWG: FIT for Screening

Colorectal cancer screening and choice of the positive cut–off level. Are French decision-making criteria optimal in regards to a person’s equal access to colonoscopy in regards to advanced neoplasia risk?
Aldis Kaufmanis (France)
IFCC Update
Sally Benton (UK)

EWG: Image Enhanced Endoscopy and Endoscopic Therapy

What we need from AI in clinical practice
Tom Eelbode (Belgium)

EWG: Right-Sided Lesions and Interval Cancers

Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death
Chyke Doubeni (USA)
How can application of the WEO consensus on PCCRC aetiology help reduce rates
Nick Burr (UK)
PCCRC rate in the Dutch CRC program, work in progress
Manon Spaander (The Netherlands)

Case Studies Meeting
IARC´s stock take of CRC Screening in Europe
Carlo Senore (Italy)
CRC screening in middle income countries
Rolando Camacho (WHO Europe Consultant)
Approaches to Colonoscopy Quality in Screening
Roland Valori (UK)
Case Study: Portugal – Current Challenges
Vitor Rodrigues (Portugal)
Case Study: Finland – New plans for FIT with a Difference (different thresholds for men and women)
Tytti Sarkeala (Finland)
Case Study: Romania – Developing screening with help from EU and Successful Programs in Italy
Mircea Manuc (Romania)
Case Study: Slovenia – An Early and Successful Organized Population based Screening Program
Dominika Novak-Mlakar (Slovenia)
Case Study: Sweden: Implementation process
Charlotta Sävblom (Sweden)

Colorectal Cancer Screening Committee Meeting San Diego (Americas)
DDW 2019 | May 17, 2019 |Program

Session 1: Tribute to Professor Wendy Atkin

Remembering Professor Wendy Atkin
David Ransohoff (USA)
Using FIT for post-polypectomy surveillance
Manon Spaander (the Netherlands)
Debate: A once only colonoscopy? Surveillance does not add much.
– Jeffrey Lee (USA)
False – Samir Gupta (USA)
Debate: Adenoma Detection Rate: Have we gone too far?
We have
– Sameer Saini (USA)
We have not
– Peter S. Liang (USA)

Session 2: Recent Advances in Science and Technology

Young onset CRC and genetic risk factors
Douglas Corley (USA)
CRC and microbiome signature
Mingyang Song (USA)

Session 4: Family history and Population Screening

Family history and CRC screening: the Canadian consensus
Jill Tinmouth (Canada)
Familial risk in those with a first degree relative with an advanced adenoma
Jennifer Kolb (USA)
Cost-effectiveness and national impact of initiating average-risk CRC screening at age 45 instead of 50
Uri Ladabaum (USA)

Expert Working Group

EWG: Right-Sided Lesions and Interval Cancers

PCCRC in Lynch
Francesc Balaguer (Spain)

EWG: Image Enhanced Endoscopy and Endoscopic Therapy 

AI – Prediction of deep cancer invasion
Leon Moons (Netherlands)
Priorities, challenges and barriers in implementing Artificial perception/intelligence in CRC screening and surveillance?
Michael Byrne (Canada)

Colorectal Cancer Screening Committee Meeting Prague (Europe)
ESGE Days 2019 | April 4, 2019 | Program

Session 1: Introductory session

Principles of Organized Screening
Linda Rabeneck (Canada)
Results of RCTs of CRC screening
Jaroslaw Regula (Poland)
Ongoing RCTs of CRC screening – expected information
Rodrigo Jover (Spain)
Original Research: Adenoma Detection Rate And Colonoscopy Indication: Beyond Screening Procedures
Carolina Mangas-Sanjuan (Spain)

Session 2: Colonoscopy in FIT(+) persons

Adjusting existing colonoscopy quality indicators for FIT(+) persons
Rodrigo Jover (Spain)
Need for new colonoscopy quality indicators for FIT(+) persons?
Cesare Hassan (Italy)
Organizational issues for Endoscopy units providing colonoscopy in FIT(+) persons
Evelien Dekker (The Netherlands)
Normal colonoscopy in FIT(+) persons: Dilemmas
Krish Ragunath (UK)
Original research: Interval CRCs after negative FIT in a 13-year Screening Program
Cesare Hassan (Italy)


Colorectal Cancer Screening Committee Meeting Vienna (Europe)
UEG Week 2018 | October 19, 2018 | Program    

Session 1: Endoscopy / Latest developments 

Artificial intelligence
Rodrigo Jover (Spain)
Prediction of lymph node metastasis (LNM) in T1 CRCs
Leon Moons (Netherlands)
Is there justification for levels of polyp competency?
Roland Valori (UK)

Session 2: Updates from screening programs 

Status of the screening program in the Canton of Vaud, Switzerland
Kevin Selby (Switzerland)
Need for colorectal cancer screening in Saudi Arabia
Samar Alhomoud (Saudi Arabia)
Initial findings from the Scottish Bowel Screening Program after changing to FIT
Judith Strachan (UK)
Colorectal cancer screening in the regions of the Russian Federation
Stanislav Konovalov (Russia)
Comparative analysis of the performance of EU screening programs
Carlo Senore (Italy)

Session 3: Should we start screening earlier?

Screening start age in light of new ACS guidelines
Charles Kahi (USA)

Session 4: Trends and risk stratification

Intelligent use of FIT
Stephen Halloran (UK)

Expert Working Group

EWG: WEO Coalition to Reduce Inequities in CRC Screening 

Development and pilot-testing of a Colorectal Cancer Screening Decision Aid for individuals with low health literacy
Mirjam Fransen (Netherlands)
Interventions to increase uptake in central London
Robert Kerrison (England)

EWG: FIT for Screening 

Detectability characteristics
Callum Fraser (UK)
Dynamic changes of faecal haemoglobin to assess the risk of advanced colorectal lesions
Josep Auge (Spain)
Update on the colorectal cancer screening in East Europe and Central Asia
Marcis Leja and Anna Krigere (Latvia)
Status of organised screening programs with FIT around the world
Graeme Young (Australia)

EWG: Right-Sided Lesions and Interval Cancers

PCCRC in high-risk cohorts – IBD
Nick Burr (UK)
PCCRC in high-risk cohorts – Lynch syndrome
Francesc Balaguer (Spain)
Right-sided cancer – is it down to a field effect?
James East (UK)

Colorectal Cancer Screening Committee Meeting Mar del Plata (South America)
GASTRO 2018 | September 28, 2018 | Program

Rising Burden of Colorectal Cancer in Latin America
Linda Rabeneck (Canada)
Novedades en preparación para colonoscopia
Eduardo Coghlan (Argentina)
How to start a Screening Program: Uruguay Experience
Eduardo Fenocchi (Uruguay)
Quality of Screening Colonoscopy – how to improve ADR
Roque Saenz (Chile)
Interval Cancers
Asadur Jorge Tchekmedyian (Uruguay)
Screening Program in Argentina: Lessons learned
Julia Ismael (Argentina)

Colorectal Cancer Screening Committee Meeting Washington (Americas)
DDW 2018 | June 1, 2018 | Program

Session 1: FIT

Comparison of different FIT kits in the Dutch CRC screening program
Clasine de Klerk (Netherlands)
Reasons for non-follow up after a positive FIT in the Dutch CRC  screening program
Lucinda Bertels (Netherlands)

Session 2: Colonoscopy Quality

Management of pT1 polyps
Maria Pellisé (Spain)
Colonoscopy Upskilling
Donald MacIntosh (Canada)

Session 3: Screening and Surveillance

CTC vs. Colonoscopy for surveillance after CRC
David Weinberg (USA)
Number of adenomas Needed to Remove (NNR) and Dwell time avoided – metrics for assessing screening Efficiency
Paul Pinsky (USA)
Evaluation and comparison of the effectiveness of CRC screening tests: The IARC Handbook
Béatrice Lauby-Secretan (France)
CRC screening at age 45 – What does the modeling suggest?
Elisabeth Peterse (Netherlands)

Session 4: New Technology and New Understandings/Realizations

Rates and complications of surgery for non-malignant polyps
Anne Peery (USA)
Genetics in young onset CRC
Elena Stoffel (USA)
Deep learning for prediction of advanced neoplasia
Hyo-Joon Yang (Korea)
Deep learning for real time histologic differentiation
Michael Byrne (Canada)

The WEO CRC Screening Committee 20th Anniversary
A Historical Recounting – Graeme Young (Australia)

Expert Working Group

EWG: Right-Sided Lesions and Interval Cancers 

Serrated polyp detection rates and factors associated with detection
Seth Crockett (USA)
PCCRC: where next?
Douglas Corley, USA

EWG: Colonoscopy Screening Trials

National Colonoscopy Study (NCS)
Ann Zauber, USA
Predictive Modeling based on NCS
Reinier Meester, USA
Douglas Robertson, USA
Enrique Quintero, Spain
NordiCC Trial 
Magnus Loberg, Norway

EWG: WEO Coalition to Reduce Inequities in CRC Screening

EWG: FIT for Screening

A Swedish update from SCREESCO
Rolf Hultcrantz, Sweden
Effectiveness of WhatsApp reminder on compliance of colorectal cancer screening
Thomas Lam, Hong Kong
Detection in subsequent screen round in the Netherlands: results for two cut-off levels
Arthur Kooyker, The Netherlands
The Brazilian Pilot, an update
Adriana Safatle-Ribeiro, Brazil

EWG: Surveillance after Colorectal Neoplasia 

General assumptions for surveillance guidelines: endpoints, cutoffs and comparators
Rodrigo Jover (Spain)
Performance targets for lesion detection in Surveillance
Uri Ladabaum (USA)
More vs. less intensive surveillance after polypectomy: Results from microsimulation modeling
Reinier Meester (USA)

EWG: Image Enhanced Endoscopy (IEE) 

Computer aided optical diagnosis of polyps
Michael Byrne (Canada)


Colorectal Cancer Screening Committee Meeting Brasil (South America)
SBAD 2017 | November 11, 2017 |Program

Session 1

Colorectal cancer: Why prevent it?
Linda Rabeneck (Canada)
Screening for colorectal cancer: Global vision
Linda Rabeneck (Canada)
How to start a screening program?
Roque Saenz (Chile)

Pilot studies in the prevention of colorectal cancer in Brazil

Projeto Belterra
Marcelo Averbach (Brazil)
Prevenção do CCR no Hospital Universitário de São Paulo
Luis Masuo Maruta (Brazil)

Session 2

What’s the best test for population screening and surveillance
Heiko Pohl (USA)
What’s the best test for population screening and surveillance
Heiko Pohl (USA)
Quality of screening colonoscopy
Heiko Pohl (USA)
Interval cancers
Heiko Pohl (USA)

Colorectal Cancer Screening Committee Meeting Barcelona (Europe)
UEG Week 2017 | October 27, 2017 | Program

Session 2: Novel Use of Tests

Colon capsule in FIT+
Gunnar Baatrup (Denmark)
CRC risk stratification module
M Azzam Kayasseh (UAE)
Novel optical sensor in toilet
Shlomo Lewkowicz (Israel)

Session 3: FIT

Risk scoring in symptomatic patients incorporating FIT
Jayne Digby (Scotland)
FIT: A Tale of Two Settings
Callum G Fraser (Scotland)
Comparison of FIT performance in screening programs
Carlo Senore (Italy)

Session 4: Quality 

Quality measures for individuals, institutions and programs
Roland Valori (UK)
ESGE Quality indicators: implementation in ongoing programs
Cesare Hassan (Italy)
Diminutive polyps and high risk status
Jasper Vleugels (Netherlands)

Session 5: Screening Program Updates 

Results from the Danish colorectal screening program
Morten Rasmussen (Denmark)
Impact of gFOBT screening in England on CRC incidence and mortality
Richard F A Logan (UK)

Expert Working Group

EWG: Surveillance after Colorectal Neoplasia 

Aim of the Project
Rodrigo Jover (Spain)
Methodological Approaches
Cesare Hassan (Italy)
Endpoints for Surveillance Studies
Michael Bretthauer (Norway)
Potential PICOs
Carlo Senore (Italy)
WEO Update of Evidences about Surveillance 

EWG: Right-Sided Lesions and Interval Cancers

WEO Consensus on PCCRC
Iosif Beintaris (UK)
Natural history of right-sided lesions
Jasper Vleugels (The Netherlands)
Optimal KPI for right-sided lesions
James East (UK)
Should right-sided lesions be surveilled differently than left-sided? Paulina Wieszczy (Poland)
Expert Working Group Report

EWG: FIT for Screening

Ernst Kuipers (The Netherlands), Sally Benton (UK)
The Dutch colorectal cancer screening programme: first and second round
Esther Toes (The Netherlands)
Increased Screening Cut-off Levels and Impact of a Plasma Protein Algorithm
Hans Jørgen Nielsen (Denmark)
Comparison of surveillance in low risk adenomas: Colonoscopy vs. FIT
Isabel Portillo (Spain)
The Risk of Missing Upper Gastrointestinal Cancer in Fitpositives in a Colorectal Cancer Screening Program
Manon van der Vlugt (The Netherlands)
FIT ‐ Analytical Standardisation and Harmonisation
Sally C Benton (UK)

EWG: Coalition to Reduce Inequities in CRC Screening

Socioeconomic differences
Andrea Burón (Spain)

Colorectal Cancer Screening Committee Meeting Hong Kong (Asia-Pacific)
APDW 2017 | September 25, 2017 | Program

Session 1: New Technology I

Real-world Big Data analysis and CRC Screening
Hyun-Soo Kim (Korea)
Microbiome as a marker for CRC screening
Sunny Wong (Hong Kong)

Session 2: New Technology II  

Endocuff, EndoRings, FUSE and other devices
Rupert Leong (Australia)
A blood based biomarker for screening for colorectal cancer
KG Yeoh (Singapore)

Session 3: Original Research

Results of screening and surveillance colonoscopy in young Korean adults < 50 years
Jae Myung Cha (Korea)
Full Spectrum Endoscopy (FUSE) in the detection of inflammatory bowel disease neoplasia (FUSION)
Rupert Leong (Australia)
Molecular imaging of colonic adenomas with fluorescent tilmanocept Jeanette Méndez (USA)
VIST – new imaging techniques for in vivo characterization of colorectal polyps
Ge Nan (China)
Establishment of an algorithm to reduce the numbers of FIT screening directed colonoscopies
Hans Jørgen Nielsen (Denmark)

Session 4: New Practices

Young onset CRC worldwide: is this a new trend?
Moe Kyaw (Hong Kong)
Colonoscopy surveillance: International cohort studies
Ernst Kuipers (The Netherlands)

Colorectal Cancer Screening Committee Meeting Chicago (Americas)
DDW 2017 | May 5, 2017 | Program

Session 2: Long-term risk of colorectal cancer

Adenomas and long-term CRC risk in the PLCO trial
Benjamin Click (USA)
Long-term CRC risk in the UK FlexiSig trial
Wendy Atkin (UK)

Session 3: FIT testing

Issues and unknowns when comparing FIT tests
Esmée Grobbee (Netherlands)
USPSTF Guidlines for CRC screening: How we arrived at what we recommended
Sue Curry (USA)

Session 4: Risk groups/Evaluating Risk

Risk assessment tools
Graham Radford-Smith (Australia)
Stool DNA testing: A Closer Look at Specificity
David Ahlquist (USA)

Expert Working Group

EWG: Colonoscopy Screening Trials

Global Burden of Disease
Roque Saenz (Chile)

EWG: Right-Sided Lesions and Interval Cancers

EWG: FIT for Screening

Predictors of Timely Colonoscopy After a Positive Fecal Immunochemical Test (FIT) in the CONFIRM Study
Douglas Robertson (USA)
Success of Mailed FIT in the United States
Samir Gupta (USA)
Dutch roll out of FIT has led to an increase in cancer detection
Manon Spaander (The Netherlands)
Sample Stability 16S and metagenomics analysis in OC-Sensor sample bottles
Marcis Leja (Latvia)
FIT Resource Impact: The Calgary Experience
Robert Hilsden (Canada)

EWG: Surveillance after Colorectal Neoplasia

Surveillance after neoplasia removal
Rodrigo Jover (Spain) & Uri Ladabaum (USA)
Differences between guidelines for post-­polypectomy surveillance: is that justified?
David Lieberman (USA)
Effect of adenoma surveillance on colorectal cancer incidence: a multicentre cohort study
Wendy Atkin (UK)
FORTE: Five or Ten Year Colonoscopy for 1-­2 Non-­Advanced Adenomas Robert Schoen (USA)

EWG: Image Enhanced Endoscopy (IEE)

Summary Report
Heiko Pohl (USA) & David Hewett (Australia)

EWG: WEO Coalition to Reduce Inequities in CRC Screening